<DOC>
	<DOCNO>NCT02372877</DOCNO>
	<brief_summary>The purpose study evaluate performance AMICUS Red Blood Cell Exchange ( RBCx ) System ( Exchange Depletion/Exchange procedure ) patient sickle cell disease .</brief_summary>
	<brief_title>Evaluation AMICUS RBCx System Sickle Cell Patients</brief_title>
	<detailed_description>The goal Red Blood Cell Exchange remove patient 's red blood cell ( RBCs ) replace blood volume remove either healthy donor RBCs and/or colloid/crystalloid solution . Depending RF use , procedure consider RBC Exchange RBC Depletion/Exchange procedure . The RBC Depletion/Exchange procedure modification RBC Exchange procedure . The AMICUS RBCx protocol provide ability use various RFs include healthy donor RBCs combination fluid , saline follow RBCs . In RBC Exchange exchange portion RBC Depletion/Exchange procedure , RBC unit use RF , colloid and/or crystalloid solution use RF depletion portion RBC Depletion/Exchange procedure . A new operating protocol AMICUS Separator enable device perform Red Blood Cell Exchange ( RBCx ) procedures accordance replacement fluid ( ) ( RF ) prescribe physician patient sickle cell disease</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>Subjects â‰¥18 year old . Subjects document diagnosis type sickle cell disorder require RBC Exchange RBC Depletion/Exchange treatment . Medically stable subject previously treat sickle cell disease RBC Exchange RBC Depletion/Exchange . Subjects , subject 's legal representative , provide sign informed consent , assent applicable , prior participation . Adequate availability sickle trait negative , leukoreduced , Blood type ( ABO ) blood group , Rhesus factor D ( Rh ( D ) ) compatible , unexpired replacement RBC product . Subjects sufficient vascular access accommodate RBCx procedure determine medical staff responsible obtain intravenous access . Subjects able agree report adverse event ( AEs ) require reporting period . Procedures occur acute hospitalization . Procedures prescribe within one week discharge hospitalization . Subjects alter mental status would prohibit give understand informed consent , assent applicable , legally authorize representative . Drug abuse , alcohol abuse , factor opinion investigator could affect ability subject comply requirement protocol . Subjects experience serious adverse event associate RBCx procedure past . In opinion investigator , subject life expectancy few 30 day . Subjects refuse blood product . Subjects pregnant . Subjects fail comply site requirement cessation medication interfere increase procedure risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Sickle Cell Disease</keyword>
	<keyword>Hemoglobin ( Hb ) S Disease</keyword>
	<keyword>Hb S Disease</keyword>
	<keyword>Congenital Hemolytic Anemia</keyword>
</DOC>